FDA Publishes New Product-Specific Guidances to Facilitate Generic Drug Development

The U.S. Food and Drug Administration published a new batch of draft product-specific guidances (PSGs) for developing generic drugs and generating evidence for abbreviated new drug applications (ANDAs).